Does TAFASITAMAB-CXIX Cause Neoplasm progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Neoplasm progression have been filed in association with TAFASITAMAB-CXIX. This represents 2.7% of all adverse event reports for TAFASITAMAB-CXIX.
20
Reports of Neoplasm progression with TAFASITAMAB-CXIX
2.7%
of all TAFASITAMAB-CXIX reports
7
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm progression From TAFASITAMAB-CXIX?
Of the 20 reports, 7 (35.0%) resulted in death.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Disease progression (218)
Lymphoma (158)
Off label use (126)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Diffuse large b-cell lymphoma (32)
Malignant neoplasm progression (30)
Neutropenia (30)
Polyneuropathy (29)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TAFASITAMAB-CXIX Alternatives Have Lower Neoplasm progression Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB